The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design

被引：0
|
作者：
Rikke Mette Agesen
Amra Ciric Alibegovic
Henrik Ullits Andersen
Henning Beck-Nielsen
Peter Gustenhoff
Troels Krarup Hansen
Christoffer Hedetoft
Tonny Jensen
Claus Bogh Juhl
Susanne Søgaard Lerche
Kirsten Nørgaard
Hans-Henrik Parving
Lise Tarnow
Birger Thorsteinsson
Ulrik Pedersen-Bjergaard
机构：
[1] Nordsjællands Hospital,Department of Endocrinology and Nephrology
[2] Steno Diabetes Center Copenhagen,Department of Endocrinology M
[3] Odense University Hospital,Faculty of Health Sciences
[4] University of Southern Denmark,Department of Endocrinology
[5] Aalborg University Hospital,Department of Medical Endocrinology
[6] Steno Diabetes Center Aarhus,Department of Diabetes and Hormonal Diseases
[7] Health,Department of Endocrinology
[8] University of Aarhus,Department of Clinical Research
[9] Department of Internal Medicine,Faculty of Health and Medical Sciences
[10] Copenhagen University Hospital (Rigshospitalet),undefined
[11] Department of Medicine,undefined
[12] Sydvestjysk Sygehus,undefined
[13] Lillebælt Hospital Kolding,undefined
[14] Hvidovre University Hospital,undefined
[15] Nordsjællands Hospital,undefined
[16] Steno Diabetes Center Sjaelland,undefined
[17] University of Copenhagen,undefined
来源：
BMC Endocrine Disorders | / 19卷
关键词：
Type 1 diabetes; Nocturnal hypoglycaemia; Severe hypoglycaemia; Insulin degludec; Insulin glargine; RCT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial
    Heise, T.
    Bain, S. C.
    Bracken, R. M.
    Zijlstra, E.
    Nosek, L.
    Stender-Petersen, K.
    Rabol, R.
    Rowe, E.
    Haahr, H. L.
    DIABETES OBESITY & METABOLISM, 2016, 18 (02): : 196 - 199
  • [42] The beneficial effect of insulin degludec on nocturnal hypoglycaemia and insulin dose in type 1 diabetic patients: a systematic review and meta-analysis of randomised trials
    Zygalo, K. D.
    Golicki, D.
    Kowalska, A.
    Szypowska, A.
    ACTA DIABETOLOGICA, 2015, 52 (02) : 231 - 238
  • [43] Risk and protective factors for severe hypoglycaemia in patients with type 1 diabetes
    Wohland, T.
    Tiemann, T.
    Patzer, O. -M.
    Holstein, J.
    Kovacs, P.
    Holstein, A.
    DIABETOLOGIA, 2014, 57 : S203 - S203
  • [44] Poor sleep quality is associated with nocturnal glycaemic variability and fear of hypoglycaemia in adults with type 1 diabetes
    Martyn-Nemeth, Pamela
    Phillips, Shane A.
    Mihailescu, Dan
    Farabi, Sarah S.
    Park, Chang
    Lipton, Rebecca
    Idemudia, Esema
    Quinn, Laurie
    JOURNAL OF ADVANCED NURSING, 2018, 74 (10) : 2373 - 2380
  • [45] Effect of insulin analogues on frequency of mild hypoglycaemia in patients with type 1 diabetes and recurrent severe hypoglycaemia: the prospective, controlled HypoAna trial
    Agesen, R. M.
    Kristensen, P. L.
    Beck-Nielsen, H.
    Norgaard, K.
    Perrild, H.
    Christiansen, J. S.
    Jensen, T.
    Hougaard, P.
    Parving, H. -H.
    Thorsteinsson, B.
    Tarnow, L.
    Pedersen-Bjergaard, U.
    DIABETOLOGIA, 2013, 56 : S239 - S239
  • [46] Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial
    Pedersen-Bjergaard, Ulrik
    Kristensen, Peter Lommer
    Beck-Nielsen, Henning
    Norgaard, Kirsten
    Perrild, Hans
    Christiansen, Jens Sandahl
    Jensen, Tonny
    Hougaard, Philip
    Parving, Hans-Henrik
    Thorsteinsson, Birger
    Tarnow, Lise
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (07): : 553 - 561
  • [47] Similar risk of severe hypoglycaemia in insulin-treated Type 2 diabetes and Type 1 diabetes with normal awareness
    Akram, K
    Pedersen-Bjergaard, U
    Pramming, S
    Borch-Johansen, K
    Thorsteinsson, B
    DIABETOLOGIA, 2002, 45 : A78 - A79
  • [48] Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes - Author's response
    McAulay, V
    Frier, BM
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (01) : 2 - 3
  • [49] Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes
    Kristensen, P. L.
    Tarnow, L.
    Bay, C.
    Norgaard, K.
    Jensen, T.
    Parving, H. -H.
    Perrild, H.
    Beck-Nielsen, H.
    Christiansen, J. S.
    Thorsteinsson, B.
    Pedersen-Bjergaard, U.
    DIABETIC MEDICINE, 2017, 34 (05) : 625 - 631
  • [50] Fifty percent of patients with Type 1 diabetes and nocturnal hypoglycaemia and / or dawn phenomenon, referred for continuous subcutaneous insulin infusion therapy, can be successfully managed with insulin degludec
    Bartha, K.
    DIABETIC MEDICINE, 2019, 36 : 129 - 129
12345